Diabetes Insipidus: A Challenging Diagnosis with New Drug Therapies

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="left">Drugs</td></tr><tr><td align="left"> Lithium</td></tr><tr><td align="left"> Ofloxacin</td></tr><tr><td align="left"> Demeclocycline</td></tr><tr><td align="left"> Amphotericin B</td></tr><tr><td align="left"> Aminoglycosides</td></tr><tr><td align="left"> Cisplatin</td></tr><tr><td align="left"> Cidofovir</td></tr><tr><td align="left"> Foscarnet</td></tr><tr><td align="left"> Ifosfamide</td></tr><tr><td align="left"> Didanosine</td></tr><tr><td align="left"> Ifosfamide</td></tr><tr><td align="left">Postobstructive</td></tr><tr><td align="left">Vascular</td></tr><tr><td align="left"> Sickle cell disease and trait</td></tr><tr><td align="left"> Acute tubular necrosis</td></tr><tr><td align="left">Metabolic</td></tr><tr><td align="left"> Severe hypercalcemia</td></tr><tr><td align="left"> Severe hypokalemia</td></tr><tr><td align="left">
								Infiltration</td></tr><tr><td align="left"> Amyloidosis</td></tr><tr><td align="left"> Sjögren's syndrome</td></tr><tr><td align="left">Granulomas</td></tr><tr><td align="left"> Sarcoma</td></tr><tr><td align="left">Granulomas</td></tr><tr><td align="left"> Sarcoidosis</td></tr><tr><td align="left">Genetic</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Causes of nephrogenic diabetes insipidus.

International Scholarly Research Notices

tab2

Table 2

Table 2: Diabetes Insipidus: A Challenging Diagnosis with New Drug Therapies 